ev3 Inc. Receives CE Mark Approval for the Axium(TM) Detachable Coil System

PLYMOUTH, Minn.--(BUSINESS WIRE)--ev3 Inc. (NASDAQ:EVVV) has announced that it received CE Mark approval for its Axium Detachable Coil System (“Axium”). Axium was approved for the endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. It is also intended for use in the European Union for the treatment of peripheral vascular abnormalities.

Back to news